Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.80 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.80 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.80 |
| ▸ | POLB | P06746 | 2/20 | 0.64 |
| ▸ | ADORA1 | P30542 | 11/20 | 0.62 |
| ▸ | ADORA2A | P29274 | 6/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | SQOR | Q9Y6N5 | 1/20 | 0.56 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20041347 | 0.83 | ADORA1 (0.77) | MEN1KMT2ARXFP1ALDH1A1KDM4E | |
| SCHEMBL19313767 | 0.76 | ADORA1 (0.62) | MEN1KMT2ARXFP1ALDH1A1KDM4E | |
| SCHEMBL22115385 | 0.76 | ADORA1 (0.66) | MEN1KMT2ARXFP1ALDH1A1KDM4E | |
| SCHEMBL22208277 | 0.76 | ADORA1 (0.66) | MEN1KMT2ARXFP1ALDH1A1KDM4E | |
| SCHEMBL19305511 | 0.76 | KMT2A (0.85) | MEN1KMT2ARXFP1ALDH1A1KDM4E | |
| SCHEMBL7502850 | 0.74 | MEN1 (0.59) | MEN1KMT2ARXFP1ALDH1A1KDM4E | |
| SCHEMBL19885521 | 0.74 | HPGD (0.74) | MEN1KMT2ARXFP1ALDH1A1KDM4E | |
| SCHEMBL19313598 | 0.74 | ADORA1 (0.59) | MEN1KMT2ARXFP1ALDH1A1KDM4E | |
| SCHEMBL19313790 | 0.74 | ADORA1 (0.59) | MEN1KMT2ARXFP1ALDH1A1KDM4E | |
| SCHEMBL3369287 | 0.73 | DPP4 (0.61) | MEN1KMT2ARXFP1ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1476435-B1 | NOVEL PYRIDIN- AND PYRIMIDIN-DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2010-06-30 | — | — | EP | disclosed |
| US-7022718-B2 | Pyridine and pyrimidine derivatives | HOFFMANN-LA ROCHE INC. (US) | 2006-04-04 | — | — | US | disclosed |
| US-20050143405-A1 | Pyridine and pyrimidine derivatives | BOEHRINGER MARKUS (CH) | 2005-06-30 | — | — | US | disclosed |
| US-6867205-B2 | Pyridine and pyrimidine derivatives | HOFFMAN-LA ROCHE INC. (US) | 2005-03-15 | — | — | US | disclosed |
| EP-1476435-A1 | NOVEL PYRIDIN- AND PYRIMIDIN-DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2004-11-17 | — | — | EP | disclosed |
| WO-2003068757-A9 | NOVEL PYRIDIN- AND PYRIMIDIN-DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2004-10-07 | — | — | WO | disclosed |
| US-20030216382-A1 | Pyridine and pyrimidine derivatives | HOFFMAN-LA ROCHE INC. | 2003-11-20 | — | — | US | disclosed |
| WO-2003068757-A1 | NOVEL PYRIDIN- AND PYRIMIDIN-DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2003-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030216382-A1 | Pyridine and pyrimidine derivatives | DPP4, GPR119, G6PC1 | MEN1 3734/4885KMT2A 3893/4885RXFP1 160/4885 |
| US-20050143405-A1 | Pyridine and pyrimidine derivatives | DPP4, GPR119, PDXK | MEN1 3821/4885KMT2A 3650/4885RXFP1 439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.